Skip to main content
. Author manuscript; available in PMC: 2010 May 15.
Published in final edited form as: Cancer Res. 2009 Apr 21;69(10):4217–4224. doi: 10.1158/0008-5472.CAN-08-4915

Table 2.

Single SNP analysis of TNFSF13B SNPs and risk of NHL and NHL subtypes

ALL NHL
(n=441)
CLL/SLL
(n=123)
Follicular NHL
(n= 113)
DLBCL (n=69)
SNP Position
(bp)
Gene
region
Major/Minor
Alleles
MAF
control
OR
(95%
CI)
P-value OR
(95%
CI)
P-value OR
(95%
CI)
P-value OR
(95%
CI)
P-value
rs9514828 107719374 promoter C/T 0.49 1.01 (0.84, 1.21) 0.93 1.08 (0.82, 1.43) 0.57 1.00 (0.75, 1.34) 0.99 0.99 (0.70, 1.40) 0.95
rs8181791 107732046 intron A/G 0.37 0.91 (0.75, 1.10) 0.34 1.06 (0.78, 1.43) 0.71 1.01 (0.74, 1.37) 0.96 0.79 (0.54, 1.17) 0.24
rs1224141 107733724 intron T/G 0.234 0.77 (0.61, 0.97) 0.03 0.82 (0.57, 1.18) 0.28 0.81 (0.56, 1.16) 0.25 0.78 (0.49, 1.24) 0.29
rs12583006 107735453 intron T/A 0.25 0.75 (0.60, 0.94) 0.01 0.86 (0.61, 1.21) 0.39 0.80 (0.55, 1.14) 0.22 0.65 (0.41, 1.04) 0.07
rs12428930 107737706 intron A/C 0.25 0.75 (0.60, 0.94) 0.01 0.88 (0.63, 1.24) 0.48 0.79 (0.55, 1.14) 0.20 0.65 (0.40, 1.04) 0.07
rs10508198 107740789 intron G/C 0.30 1.21 (0.99, 1.47) 0.06 0.97 (0.71, 1.33) 0.85 1.19 (0.88, 1.62) 0.25 1.39 (0.96, 2.03) 0.08
rs1224147 107754759 intron T/C 0.234 1.18 (0.96, 1.46) 0.12 0.88 (0.62, 1.25) 0.47 1.20 (0.87, 1.67) 0.27 1.13 (0.74, 1.71) 0.58
rs9520836 107755064 intron A/G 0.26 1.01 (0.82, 1.25) 0.91 1.03 (0.75, 1.42) 0.86 1.01 (0.72, 1.42) 0.94 1.02 (0.67, 1.53) 0.94
rs7982100 107756366 intron C/T 0.007 1.94 (0.77, 4.93) 0.16 2.12 (0.60, 7.41) 0.24 1.76 (0.45, 6.94) 0.42 1.02 (0.12, 8.47) 0.99

*Odds ratio and 95% confidence interval assuming log-additive genetic model adjusted for gender, and age.